davidoff consulting firm inc.

535 neptune avenue 13h
brooklyn, new york 11224

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 28, 2013

NYS DOS ID#
4424405

County
KINGS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - DAVIDOFF CONSULTING FIRM INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • 19th-Century Diary Suggests Slaves Are Buried in Brooklyn Lot
    By MICHAEL WILSON - Friday Aug 4, 2017

    A Gowanus farmer’s writings from 1828 to 1830 describe burying them on property that includes the proposed site of a prekindergarten.

    Source: NYT > Home Page
  • Neighborhood Joint: Staubitz Market in Brooklyn: 100 Years of Sawdust, Steaks and Chops
    By ANDREW COTTO - Wednesday Jun 14, 2017

    A display contains frozen items, and the shelves are stocked with jars and cans. But there’s just one reason to visit this Boerum Hill business: meat.

    Source: NYT > Home Page
  • Can Gowanus Survive Its Renaissance?
    By ANDY NEWMAN - Friday Oct 13, 2017

    Brooklyn’s famously filthy canal is getting cleaned up. New construction is coming to the area. And not everyone is happy.

    Source: NYT > Home Page
  • MBAs are snubbing Wall Street to work at consulting firms
    By Kevin Dugan - Wednesday Aug 9, 2017

    It’s official: McKinsey & Co. is sexier than Goldman Sachs. The most sought-after jobs for MBAs are no longer on Wall Street, as more business students than ever before are instead looking to go into consulting, according to a survey released Wednesday. For the first time in eight years, consulting firms like McKinsey, Bain &...

    Source: New York Post: Business
  • Cancer drug research moving fast in immunotherapy field
    By Michelle Fay Cortez - Tuesday Sep 5, 2017

    The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.

    Source: SFGATE.com: Business and Technology News
  • Federal Jail in Brooklyn Faces a String of Sexual Assault Cases
    By JOSEPH GOLDSTEIN - Tuesday Aug 1, 2017

    The Metropolitan Detention Center has relatively few female inmates. Yet it accounts for a disproportionate number of sexual assault cases involving them.

    Source: NYT > Home Page